Anker v. G.D. Searle & Co.

126 F.R.D. 515, 1989 WL 67035
CourtDistrict Court, M.D. North Carolina
DecidedMay 26, 1989
DocketNo. M-89-20
StatusPublished
Cited by11 cases

This text of 126 F.R.D. 515 (Anker v. G.D. Searle & Co.) is published on Counsel Stack Legal Research, covering District Court, M.D. North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Anker v. G.D. Searle & Co., 126 F.R.D. 515, 1989 WL 67035 (M.D.N.C. 1989).

Opinion

ORDER

RUSSELL A. ELIASON, United States Magistrate.

Plaintiffs have noticed the deposition of Dr. Malcolm Potts, who is not a party to this action, and issued a subpoena duces tecum pursuant to Rule 45, Fed.R.Civ.P., for his testimony and for the production of 77 categories of documents. Dr. Potts responded with a motion for a protective order seeking to postpone the deposition because of his immediate travel plans, which was shortly followed by a motion to quash the subpoena duces tecum pursuant to Rule 45(b), Fed.R.Civ.P., or in the alternative, or in addition thereto, to grant a protective order pursuant to Rule 26(c), Fed.R.Civ.P. Dr. Potts has filed three affidavits setting out the factual issues as he perceives them. None of the parties have filed affidavits or submitted evidence. While this matter is ostensibly a controversy between Dr. Potts and plaintiffs, the Court has directed that defendant Searle file a response and set out its position as well.

The matter before the Court involves six lawsuits filed in the federal court in Minnesota which consolidated them for discovery purposes. As pertinent to the instant controversy, the plaintiff women allege injury to themselves from the use of an instrument known as Copper-Seven (“Cu-7”), an intrauterine device (“IUD”) which is manufactured by defendant. The product is employed by means of an inserter tube which is placed into the vagina, through the cervix, into the uterus. The device contains a tailstring extending from its lower end which is intended to assist in the removal of the device and as a means of ascertaining whether it remains properly inserted. The tailstring extends through the normally sterile cavity of the uterus, through the cervix, and into the bacteria laden vagina. It is plaintiffs’ contention that the device has been negligently designed and that the tailstring facilitates bacterial colonization and migration from the vagina to the uter[517]*517us causing increased pelvic inflammatory disease leading to inflammation, hysterectomies and/or infertility.

Plaintiffs seek to depose Dr. Potts and examine his general knowledge and education with respect to IUDs and their hazards, his association with defendant Searle and his research studies with respect to IUDs. Dr. Potts has not been listed as a witness by any party. Plaintiffs assert, however, that Dr. Potts may be a potential witness for defendant and, therefore, seek immediate access to his views. Plaintiffs base their apprehension on the fact that Dr. Potts was listed as a “percipient” witness in another IUD case brought against defendant in the federal court for the Central District of California. However, it does not appear that Dr. Potts was called as a witness in that case. Next, plaintiffs contend that Dr. Potts has personally corresponded with Searle’s attorney and provided defendant with a declaration to the effect that his studies do not show that stringless IUDs are a safe alternative compared with IUDs having string attachments. Plaintiffs claim that defendant Searle unsuccessfully attempted to introduce this report in the California litigation.

Dr. Potts has responded through three affidavits showing that he is the President and Chief Executive Officer of a not-for-profit organization known as Family International Health (“FHI”). This organization studies family planning methods. It receives support from the Agency for International Development, the National Institute of Health and private foundations, such as the Mellon, Hewlett, Ford and Packard Foundations. The FHI is the largest organization in the world for conducting clinical trials on contraception. It has a full-time staff of 150 people and works with collaborating researchers in more than 50 countries.

Dr. Potts further states that neither he nor the FHI have received any fee or compensation for the study of IUDs either with or without strings. His organization did perform a “strings-no strings” study which was funded by the Agency for International Development. The study and its conclusion are all a matter of public record. Dr. Potts specifically states that defendant did not offer, nor did he request or take from defendant, any compensation with respect to the study. He does admit that defendant, as a member of the public, requested a declaration on the results of the study and that he (Dr. Potts) provided the information as he would to any other requester.

Dr. Potts addresses the burden of the subpoena indicating that he has authored or contributed to over 200 publications, many of which discuss IUDs and one-third directly concern contraception. The FHI itself has published 66 articles on IUDs between 1980 and 1987. Dr. Potts estimates that the document requests from the subpoena could easily include over 300,000 pages. He points out that many of the requests are already available to the public through publications. Some of the items are considered to be confidential such as research protocols and investigators’ manuals.

While plaintiffs did not file contraverting affidavits, they have narrowed their document requests from 77 to 55 categories. Nevertheless, the requests are still expansive, including Dr. Potts’ curriculum vitae, all of the articles which he has written, copies of IUDs in FHI’s possession, all notes and correspondence of any nature with G.D. Searle and Monsanto companies, along with notes of any meetings at which these companies may have been present. Plaintiffs want study protocols, investigators’ manuals and related information, not only with respect to a specific study but all studies from 1985 to present involving IUDs.

Plaintiffs claim that they are entitled to expansive discovery because there is a high probability that defendant will use Dr. Potts and his studies at trial. On the other hand, they also claim that Dr. Potts is not an expert witness and they only seek facts concerning his scientific research. Dr. Potts, on the other hand, claims that he is a complete stranger to this litigation and, therefore, plaintiffs do not have any right to force him to divulge his research and in any event, the subpoena is entirely too [518]*518broad and unworkable and should be quashed in its entirety. Defendant states that, even if not designated as an expert witness by the parties, Dr. Potts would be deemed an expert witness by the Minnesota federal court based on a decision as to a similar situation in another CU-7 case recently tried there. However, he has not yet been named as an expert witness. (Most of the Minnesota cases have not yet reached the expert witness discovery stage.)

Discussion

Pursuant to Rule 45(b) and (d), Fed.R.Civ.P., a party may issue a subpoena for the purpose of taking the deposition of a non-party and also command that person to produce documentary evidence. Pursuant to Rule 45(b), a subpoena duces tecum requiring the production of documentary evidence is subject to being quashed or modified for being unreasonable, or conditionally allowed upon payment of production costs. It also may be the subject of a protective order in accordance with the provisions of Rule 26(c), Fed.R.Civ.P. Heat and Control, Inc. v. Hester Industries, Inc., 785 F.2d 1017 (Fed.Cir.1986). When presented with a motion to quash a subpoena duces tecum which would foreclose all discovery, a court should first consider the possibility of utilizing protective orders in order to reallocate the burdens and thereby permit appropriate discovery. Heat and Control, Inc. v. Hester Industries, Inc., supra at 1025;

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Accutane Litigation
233 N.C. App. 319 (Court of Appeals of North Carolina, 2014)
Schaaf v. Smithkline Beecham Corp.
233 F.R.D. 451 (E.D. North Carolina, 2005)
Flanagan v. Wyndham International Inc.
231 F.R.D. 98 (District of Columbia, 2005)
Insulate America v. Masco Corp.
227 F.R.D. 427 (W.D. North Carolina, 2005)
Mortgage Information Services, Inc. v. Kitchens
210 F.R.D. 562 (W.D. North Carolina, 2002)
Pikes Peak Family Housing, LLC v. United States
42 Cont. Cas. Fed. 77,280 (Federal Claims, 1998)
Smith v. Dow Chemical Co.
173 F.R.D. 54 (W.D. New York, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
126 F.R.D. 515, 1989 WL 67035, Counsel Stack Legal Research, https://law.counselstack.com/opinion/anker-v-gd-searle-co-ncmd-1989.